Rapport Therapeutics, Inc. Financial Overview
Rapport Therapeutics, Inc.'s market cap is currently $1.37B. The company's EPS TTM is $-0.71; its P/E ratio is -11.01; Rapport Therapeutics, Inc. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
